The Trump administration is expanding its protection of the AI industry to include robotics, as the Federal Trade Commission recently issued a sweeping ban on foreign imports of advanced robots, including humanoids, quadrupeds, and wheeled robots. This move signals a broader strategy to shield emerging sectors from foreign competition, extending beyond traditional trade approaches with China.

Meanwhile, US Immigration and Customs Enforcement collected nearly one million people's DNA last year, with most individuals having no criminal convictions. This raises significant privacy concerns about government data collection practices.

Other notable developments include China's growing dominance in future technologies, particularly in software alongside its hardware prowess, prompting concern among US tech and political leaders. Businesses are also exploring "AI tokenomics" to measure returns on substantial AI investments, while Eli Lilly is allowing early access to an unapproved obesity drug called Retatrutide.

Additional stories highlight the rise of AI-powered matchmaking services, issues with license plate reader accuracy rates, and the intersection of technology with local politics in data center development. These developments collectively illustrate the complex relationship between emerging technologies and regulatory, ethical, and societal challenges.